496 related articles for article (PubMed ID: 25897922)
1. Inflammation in HFpEF: Key or circumstantial?
van Empel V; Brunner-La Rocca HP
Int J Cardiol; 2015; 189():259-63. PubMed ID: 25897922
[TBL] [Abstract][Full Text] [Related]
2. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
3. Heart failure with preserved vs reduced ejection fraction following cardiac rehabilitation: impact of endothelial function.
Tanaka S; Sanuki Y; Ozumi K; Harada T; Tasaki H
Heart Vessels; 2018 Aug; 33(8):886-892. PubMed ID: 29392470
[TBL] [Abstract][Full Text] [Related]
4. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
[TBL] [Abstract][Full Text] [Related]
5. Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction.
Tromp J; Khan MAF; Mentz RJ; O'Connor CM; Metra M; Dittrich HC; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JGF; Givertz MM; Bloomfield DM; Van Veldhuisen DJ; Hillege HL; Voors AA; van der Meer P
JACC Heart Fail; 2017 Jul; 5(7):507-517. PubMed ID: 28624483
[TBL] [Abstract][Full Text] [Related]
6. Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.
Toledo C; Andrade DC; Lucero C; Arce-Alvarez A; Díaz HS; Aliaga V; Schultz HD; Marcus NJ; Manríquez M; Faúndez M; Del Rio R
J Physiol; 2017 Apr; 595(8):2479-2495. PubMed ID: 28181258
[TBL] [Abstract][Full Text] [Related]
7. Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction.
Tromp J; Westenbrink BD; Ouwerkerk W; van Veldhuisen DJ; Samani NJ; Ponikowski P; Metra M; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Lang CC; Ng LL; Zannad F; Zwinderman AH; Hillege HL; van der Meer P; Voors AA
J Am Coll Cardiol; 2018 Sep; 72(10):1081-1090. PubMed ID: 30165978
[TBL] [Abstract][Full Text] [Related]
8. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.
Melenovsky V; Hwang SJ; Redfield MM; Zakeri R; Lin G; Borlaug BA
Circ Heart Fail; 2015 Mar; 8(2):295-303. PubMed ID: 25593126
[TBL] [Abstract][Full Text] [Related]
9. Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort.
Quiroz R; Doros G; Shaw P; Liang CS; Gauthier DF; Sam F
Am J Cardiol; 2014 Feb; 113(4):691-6. PubMed ID: 24484862
[TBL] [Abstract][Full Text] [Related]
10. Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study.
Takada T; Sakata Y; Miyata S; Takahashi J; Nochioka K; Miura M; Tadaki S; Shimokawa H;
Eur J Heart Fail; 2014 Mar; 16(3):309-16. PubMed ID: 24464774
[TBL] [Abstract][Full Text] [Related]
11. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.
Schwartzenberg S; Redfield MM; From AM; Sorajja P; Nishimura RA; Borlaug BA
J Am Coll Cardiol; 2012 Jan; 59(5):442-51. PubMed ID: 22281246
[TBL] [Abstract][Full Text] [Related]
12. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.
van Heerebeek L; Hamdani N; Falcão-Pires I; Leite-Moreira AF; Begieneman MP; Bronzwaer JG; van der Velden J; Stienen GJ; Laarman GJ; Somsen A; Verheugt FW; Niessen HW; Paulus WJ
Circulation; 2012 Aug; 126(7):830-9. PubMed ID: 22806632
[TBL] [Abstract][Full Text] [Related]
13. Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.
Franssen C; Chen S; Unger A; Korkmaz HI; De Keulenaer GW; Tschöpe C; Leite-Moreira AF; Musters R; Niessen HW; Linke WA; Paulus WJ; Hamdani N
JACC Heart Fail; 2016 Apr; 4(4):312-24. PubMed ID: 26682792
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction.
Wong LL; Armugam A; Sepramaniam S; Karolina DS; Lim KY; Lim JY; Chong JP; Ng JY; Chen YT; Chan MM; Chen Z; Yeo PS; Ng TP; Ling LH; Sim D; Leong KT; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Lam CS; Jeyaseelan K; Richards AM
Eur J Heart Fail; 2015 Apr; 17(4):393-404. PubMed ID: 25619197
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic impact of heart failure with preserved versus reduced ejection fraction in patients with mild symptoms].
Jung P; Huber T; Müller M; König A; Krötz F; Sohn HY
Dtsch Med Wochenschr; 2012 Apr; 137(14):706-10. PubMed ID: 22454198
[TBL] [Abstract][Full Text] [Related]
16. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.
Brouwers FP; de Boer RA; van der Harst P; Voors AA; Gansevoort RT; Bakker SJ; Hillege HL; van Veldhuisen DJ; van Gilst WH
Eur Heart J; 2013 May; 34(19):1424-31. PubMed ID: 23470495
[TBL] [Abstract][Full Text] [Related]
17. Diagnosing heart failure with preserved ejection fraction.
Becher PM; Lindner D; Fluschnik N; Blankenberg S; Westermann D
Expert Opin Med Diagn; 2013 Sep; 7(5):463-74. PubMed ID: 23930995
[TBL] [Abstract][Full Text] [Related]
18. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH
Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866
[TBL] [Abstract][Full Text] [Related]
19. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
[TBL] [Abstract][Full Text] [Related]
20. Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction.
Maeder MT; Kaye DM
Int J Cardiol; 2012 Mar; 155(2):249-56. PubMed ID: 21035207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
